C-X-C motif chemokine ligand 1 messenger RNA (CXCL1 mRNA) (CXCL1 mRNA)

C-X-C motif chemokine ligand 1 (CXCL1) messenger RNA, commonly referred to as GRO-alpha mRNA, is the template for the synthesis of the CXCL1 chemokine. This molecule is a critical mediator of the innate immune system, primarily functioning to recruit and activate neutrophils via the CXCR2 receptor (NCBI Gene ID: 2919). In various malignancies, such as melanoma and colorectal cancer, CXCL1 mRNA is significantly upregulated, driving tumor-associated angiogenesis and the recruitment of immunosuppressive cells to the tumor microenvironment (PubMed: 25605115). As a therapeutic target, CXCL1 mRNA is approached using RNA interference (RNAi) technologies, such as siRNAs, to silence the production of the pro-inflammatory and pro-tumorigenic protein (PubMed: 31435104). This strategy aims to overcome the limitations of small molecule inhibitors by providing high specificity and reducing the systemic levels of the chemokine. However, therapeutic challenges include ensuring efficient delivery to target tissues and managing the potential for impaired host defense against pathogens due to suppressed neutrophil activity (UniProt: P09341). Additionally, the high sequence homology among CXC chemokines requires precise design of RNAi agents to avoid off-target silencing of related genes.

Other names

GRO-alpha mRNAGrowth-regulated alpha protein mRNAMelanoma growth stimulatory activity alpha mRNAGRO1 mRNASCYB1 mRNANAP-3 mRNA

RNA interference (RNAi) or antisense-mediated degradation of the mRNA transcript, preventing the translation of the CXCL1 protein.